業 績 一 覧 2023

原著

1. Oda K, Aoki D, Tsuda H, Nishihara H, Aoyama H, Inomata H, Shimada M, Enomoto T. Japanese nationwide observational multicenter study of tumor BRCA1/2 variant testing in advanced ovarian cancer Cancer Sci. 2023 Jan;114(1):271-280.
2. Abiko S, Shimizu Y, Ishikawa M, Inoue M, Nakajima K, Kohya R, Hirata K, Suzuki K, Sugiura R, Miyamoto S, Kinoshita K, Hatanaka K, Yamamoto Y, Naruse H, Miyagishima T, Sakamoto N. Effects of activation of an alcohol metabolic gene, cigarette smoking, and alcohol intake on the incidence of metachronous gastric cancer in patients who underwent endoscopic resection for gastric cancer: A multicenter retrospective pilot study JGH Open. 2023 Mar; 31;7(4):305-310.
3. Kobayashi H, Kosaka T, Nakamura K, Kimura T, Nishihara H, Oya M Genomic analysis of aggressive ductal adenocarcinoma of the prostate Cancer Med 2023 Apr;12(7):8445-8451.
4. Yanagita E, Yamada H, Kobayashi T, Aimono E, Nakamura K, Hirasawa A, Nishihara H. The DNA integrity number and concentration are useful parameters for successful comprehensive genomic profiling test for cancer using formalin-fixed paraffin embedded tissue. Pathol Int. 2023 May;73(5):198-206.
5. Suzuki S, Tsuda H, Bandoh N, Goto T, Uemura A, Aoyama T, Nishio A, Makino S, Yamaguchi T, Aimono E, Nishihara H, Harabuchi Y. Diffuse-Type Tenosynovial Giant Cell Tumor Arising in the Temporomandibular Joint Extending to the External Auditory Canal: A Case Report and Literature Review. Ear Nose Throat J. 2023 May;102(5):291-296.
6. Hsu CY, Yanagi T, Maeda T, Nishihara H, Miyamoto K, Kitamura S, Tokuchi K, Ujiie H. Eribulin inhibits growth of cutaneous squamous cell carcinoma cell lines and a novel patient-derived xenograft. Sci Rep. 2023 May; 27;13(1):8650.
7. Anno T, Tanaka N, Takamatsu K, Hakozaki K, Kufukihara R, Baba Y, Takeda T, Matsumoto K, Morita S, Kosaka T, Mikami S, Nishihara H, Mizuno R, Oya M. Prognostic role of the innate immune signature CD163 and "eat me" signal calreticulin in clear cell renal cell carcinoma. Cancer Immunol Immunother. 2023 Jun;72(6):1779-1788.
8. Morimoto Y, Matsuda S, Kawakubo H, Nakamura K, Kobayashi R, Hisaoka K, Okui J, Takeuchi M, Aimono E, Fukuda K, Nakamura R, Saya H, Nishihara H, Kitagawa Y. Tumor Burden Monitoring with Circulating Tumor DNA During Treatment in Patients with Esophageal Squamous Cell Carcinoma Ann Surg Oncol. 2023 Jun;30(6):3747-3756.
9. Takamatsu R, Nakamura K, Suzuki O, Okada C, Mori R, Kawano R, Hayashi H, Ishikawa M, Aimono E, Nohara S, Tanishima S, Ueki A, Ishida H, Nishihara H. Clinical predominance of whole-exome sequencing to evaluate microsatellite instability status Cancer Sci. 2023 Jul;114(7):2848-2859.
10. Kage H, Oda K, Muto M, Tsuchihara K, Okita N, Okuma Y, Kikuchi J, Shirota H, Hayashi H, Kokuryo T, Sakai D, Hirasawa A, Kubo M, Kenmotsu H, Akiyama N, Shinozaki-Ushiku A, Tanabe M, Ushiku T, Miyagawa K, Seto Y. Human resources for administrative work to carry out a comprehensive genomic profiling test in Japan. Cancer Sci. 2023 Jul;114(7):3041-3049.
11. Naito Y, Mishima S, Akagi K, Hayashi N, Hirasawa A, Hishiki T, Igarashi A, Ikeda M, Kadowaki S, Kajiyama H, Kato M, Kenmotsu H, Kodera Y, Komine K, Koyama T, Maeda O, Miyachi M, Nishihara H, Nishiyama H, Ohga S, Okamoto W, Oki E, Ono S, Sanada M, Sekine I, Takano T, Tao K, Terashima K, Tsuchihara K, Yatabe Y, Yoshino T, Baba E. Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors. Int J Clin Oncol. 2023 Jul;28(7):827-840.
12. Akahane T, Isochi-Yamaguchi T, Hashiba-Ohnuki N, Bandoh N, Aimono E, Kato Y, Nishihara H, Kamada H, Tanimoto A. Cancer gene analysis of liquid-based cytology specimens using next-generation sequencing: A technical report of bimodal DNA- and RNA-based panel application Diagn Cytopathol. 2023 Aug;51(8):493-500.
13. Mishima S, Naito Y, Akagi K, Hayashi N, Hirasawa A, Hishiki T, Igarashi A, Ikeda M, Kadowaki S, Kajiyama H, Kato M, Kenmotsu H, Kodera Y, Komine K, Koyama T, Maeda O, Miyachi M, Nishihara H, Nishiyama H, Ohga S, Okamoto W, Oki E, Ono S, Sanada M, Sekine I, Takano T, Tao K, Terashima K, Tsuchihara K, Yatabe Y, Yoshino T, Baba E. Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with high tumor mutational burden tumors. Int J Clin Oncol. 2023 Aug;28(8):941-955.
14. Ozawa A, Iwasaki M, Yokoyama K, Tsuchiya J, Kawano R, Nishihara H, Tateishi U. Correlation between choline kinase alpha expression and 11C-choline accumulation in breast cancer using positron emission tomography/computed tomography: a retrospective study. Sci Rep. 2023 Oct; 17;13(1):17620.
15. Machino H, Dozen A, Konaka M, Komatsu M, Nakamura K, Ikawa N, Shozu K, Asada K, Kaneko S, Yoshida H, Kato T, Nakayama K, Saloura V, Kyo S, Hamamoto R. Integrative analysis reveals early epigenetic alterations in high-grade serous ovarian carcinomas. Exp Mol Med. 2023 Oct;55(10):2205-2219.
16. Nakamura Y, Mizukami H, Tanese K, Fusumae T, Hirai I, Amagai M, Takamatsu R, Nakamura K, Nishihara H, Takimoto T, Ueno M, Saya H, Funakoshi T. Role of androgen signaling in androgen receptor-positive extramammary Paget's disease: Establishment of organoids and their biological analysis as a novel therapeutic target. J Dermatol Sci. 2023 Oct;112(1):23-30.
17. Mishima S, Naito Y, Akagi K, Hayashi N, Hirasawa A, Hishiki T, Igarashi A, Ikeda M, Kadowaki S, Kajiyama H, Kato M, Kenmotsu H, Kodera Y, Komine K, Koyama T, Maeda O, Miyachi M, Nishihara H, Nishiyama H, Ohga S, Okamoto W, Oki E, Ono S, Sanada M, Sekine I, Takano T, Tao K, Terashima K, Tsuchihara K, Yatabe Y, Yoshino T, Baba E. Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with DNA mismatch repair deficient (dMMR) tumors, third edition. Int J Clin Oncol . 2023 Oct;28(10):1237-1258.
18. Kitazawa S, Chiyoda T, Nakamura K, Sakai K, Yoshihama T, Nishio H, Kobayashi Y, Iwata T, Banno K, Yamagami W, Nishihara H, Aoki D. Clinical availability and characteristics of multigene panel testing for recurrent/advanced gynecologic cancer. Int J Clin Oncol. 2023 Nov;28(11):1554-1562.

症例報告

1. Kubota A, Bandoh N, Goto T, Matsumoto KI, Yamaguchi-Ishochi T, Kato Y, Nishihara H, Takei H. Epstein‑Barr virus‑associated lymphoepithelial carcinoma arising in the parotid gland: A case report and literature review Mol Clin Oncol. 2023 Feb; 10;18(3):24.
2. Inoue M, Ishikawa M, Tanaka S, Zhang X, Okada H, Miyasighima T. Infection with male and female Trichuris trichiura diagnosed in a non-endemic area Clin Case Rep. 2023 Apr; 23;11(4):e7250.
3. Bandoh N, Kubota A, Takeda R, Sakaue S, Goto T, Baba S, Hashiba N, Kato Y, Nishihara H. Renal Cell Carcinoma Metastasizing to the Cricoid Cartilage Presenting With Subglottic Stenosis: A Case Report and Literature Review. Ear Nose Throat J. 2023 May; 26:1455613231177188.